• Study on the Effects and Safety of Bulevirtide, Peginterferon Alfa-2a, and Entecavir in Patients with Chronic Hepatitis D

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Ireland Italy The Netherlands +4

  • Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Finland +8

  • Study on the Effects of Rituximab for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Drugs:
    Germany

  • Study on the Safety and Effects of UX701 Gene Therapy for Adults with Wilson Disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark France Germany Italy Portugal Spain

  • Study on Pain in Parkinson’s Disease: Examining the Effects of 18F-MPPF in Patients with and without Pain

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Safety and Effectiveness of TransCon CNP for Children and Adolescents with Achondroplasia

    Recruiting

    2 1 1
    Austria Denmark Finland France Germany Ireland +4

  • Study of Semaglutide for Treating Prediabetes in Women with Previous Gestational Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

  • Study on the Effectiveness and Safety of Indacaterol Acetate/Mometasone Furoate vs. Budesonide for Children Aged 6-11 with Asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Czechia Greece Hungary Italy +3

  • Study on Meniere’s Disease: Comparing Methylprednisolone and Placebo for Patients with Unilateral Meniere’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

powered by